Andera Partners | WebDisclosure

Switch to English

8296	Sociétés
114902	Mots-clés
55328	Articles
62458	Communiqués

Accueil
Sociétés
Andera Partners

BRÈVE

publiée le 13/11/2024 à 13:05, il y a 8 jours

Andera Partners se développe à l'international avec un nouveau bureau à Madrid

Expansion Internationale Capital-investissement Partenaires Andera Bureau De Madrid Marché Espagnol
BRÈVE

publiée le 13/11/2024 à 13:05, il y a 8 jours

Andera Partners Expands Internationally with New Madrid Office

Private Equity International Expansion Andera Partners Madrid Office Spanish Market
COMMUNIQUÉ DE PRESSE

publié le 13/11/2024 à 13:00, il y a 8 jours

ANDERA PARTNERS CONTINUES ITS INTERNATIONAL EXPANSION AND ANNOUNCES THE OPENING OF A MADRID OFFICE
Andera Partners announces opening of Madrid office for private equity strategy in Spain led by Gonzalo Boada, continuing international expansion

Private Equity International Expansion Andera Partners Madrid Office Gonzalo Boada
BRÈVE

publiée le 26/07/2024 à 09:05, il y a 3 mois 26 jours

Andera Partners co-dirige une levée de fonds de 196 millions de dollars pour Kestra Medical

Financement Équipement Médical Partenaires Andera Raymond W. Cohen Défibrillateur Portable
BRÈVE

publiée le 26/07/2024 à 09:05, il y a 3 mois 26 jours

Andera Partners Co-Leads $196 Million Round for Kestra Medical

Medical Devices Financing Andera Partners Wearable Defibrillator Raymond W. Cohen
COMMUNIQUÉ DE PRESSE

publié le 26/07/2024 à 09:00, il y a 3 mois 26 jours

Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors
Andera Partners co-leads $196 million financing round for Kestra Medical, appoints Raymond W. Cohen to the board. Kestra develops a wearable defibrillator vest for cardiac patients

Financing Andera Partners Wearable Defibrillator Raymond W. Cohen Kestra Medical
BRÈVE

publiée le 25/07/2024 à 10:05, il y a 3 mois 27 jours

JenaValve Technology, société de portefeuille d'Andera Partners, acquise par Edwards Lifesciences

Acquisition Capital-investissement Approbation De La FDA Innovations Cardiovasculaires Technologie Des Valves Cardiaques
BRÈVE

publiée le 25/07/2024 à 10:05, il y a 3 mois 27 jours

Andera Partners’ Portfolio Company JenaValve Technology Acquired by Edwards Lifesciences

Acquisition Private Equity FDA Approval Cardiovascular Innovations Heart Valve Technology
COMMUNIQUÉ DE PRESSE

publié le 25/07/2024 à 10:00, il y a 3 mois 27 jours

Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences
Andera Partners' portfolio company JenaValve Technology acquired by Edwards Lifesciences, marking a significant milestone in cardiovascular innovation with FDA approval expected by late 2025

Acquisition Andera Partners Edwards Lifesciences JenaValve Technology Cardiovascular Innovation
BRÈVE

publiée le 25/07/2024 à 09:35, il y a 3 mois 27 jours

TRiCares Secures $50 Million Series D Financing for Clinical Advancements

Clinical Trials Andera Partners TRiCares Series D Financing Heart Valve System

Les Echos

Publié le 21/11/2024 à 06:58, il y a 6 heures 40 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 40 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 6 heures 40 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 17 heures 30 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 18 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 13:00, il y a 38 minutes

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Publié le 21/11/2024 à 13:00, il y a 38 minutes

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Publié le 21/11/2024 à 13:00, il y a 38 minutes

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Publié le 21/11/2024 à 13:00, il y a 38 minutes

Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Publié le 21/11/2024 à 13:00, il y a 38 minutes

Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 13:15, il y a 23 minutes

NOTICE OF ANNUAL GENERAL MEETING
Publié le 21/11/2024 à 12:35, il y a 1 heure 3 minutes

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 1 heure 23 minutes

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Publié le 21/11/2024 à 12:06, il y a 1 heure 31 minutes

IVU AG publishes Quarterly Report Q3-2024
Publié le 21/11/2024 à 12:00, il y a 1 heure 38 minutes

Holding(s) in Company